摘要
目的探究强力定眩胶囊结合甲磺酸倍他司汀对眩晕症患者临床疗效。方法选择近年该院收治的94例眩晕症患者,随机分为两组,各47例,对照组予以甲磺酸倍他司汀片治疗,观察组在此基础上辅以强力定眩胶囊治疗,14 d为一疗程,对比两组临床疗效、脑血流动力学及治疗安全性。结果观察组治疗总有效率为91.49%,高于对照组的76.60%(P<0.05)。观察组治疗后的左椎动脉(LVA)、右椎动脉(RVA)、基底动脉(BA)血流动力均高于对照组(P<0.05)。两组治疗无严重药物不良反应。结论两药联合治疗眩晕症的治疗效果显著,并可改善脑血流动力学,且治疗安全可靠。
【Objective】To explore the clinical effect of Qiangli Dingxuan capsule combined with betahistine mesylate on vertigo patients.【Methods】Ninety-four patients with vertigo admitted to our hospital in recent years were randomly divided into two groups,47 cases in each group.The control group was treated with betahistine mesylate tablets.The observation group was treated with Qiangli Dingxuan Capsule on this basis.The course of treatment was 14 days.The clinical efficacy,cerebral hemodynamics and treatment safety of the two groups were compared.【Results】The total effective rate of the observation group was 91.49%,higher than 76.60%of the control group(P<0.05).The levels of left vertebral artery(LVA),right vertebral artery(RVA)and basilar artery(BA)in the observation group were higher than those in the control group(P<0.05).There were no serious adverse drug reactions in the two groups.【Conclusion】The treatment of vertigo with the combination of the two drugs is effective,and can improve cerebral hemodynamics,which is safe and reliable.
作者
穆素会
MU Suhui(Department of Neurology,Zhengzhou Yihe Hospital,Zhengzhou,Henan 450000,China)
出处
《中国医学工程》
2019年第9期64-66,共3页
China Medical Engineering
